Skip to main content
Clinical Trials/NCT00793026
NCT00793026
Completed
Phase 3

Safety Dermatological Evaluation: Genital Mucous Irritation - Test in Use - Dermacyd Breeze Pocket BR (Lactic Acid).

Sanofi1 site in 1 country30 target enrollmentNovember 2008

Overview

Phase
Phase 3
Intervention
Dermacyd Breeze Pocket BR (Lactic Acid)
Conditions
Hygiene
Sponsor
Sanofi
Enrollment
30
Locations
1
Primary Endpoint
Good acceptability
Status
Completed
Last Updated
17 years ago

Overview

Brief Summary

The purpose of this study is to prove the safety of the gynaecological formulation in normal conditions of use.

Registry
clinicaltrials.gov
Start Date
November 2008
End Date
November 2008
Last Updated
17 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Sponsor
Sanofi

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

1

Dermacyd Breeze Pocket BR (Lactic Acid)

Intervention: Dermacyd Breeze Pocket BR (Lactic Acid)

Outcomes

Primary Outcomes

Good acceptability

Time Frame: Throughout the study

Absence of irritation

Time Frame: Throughout the study

Study Sites (1)

Loading locations...

Similar Trials